| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6000778 | Thrombosis Research | 2015 | 7 Pages |
Abstract
We observed heterogeneous duration of anticoagulant treatment for the secondary prevention of VTE. A substantial proportion of patients, in particular those with VTE secondary to transient risk factors, may be exposed to a possibly unnecessary risk of bleeding.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Walter Ageno, Angel Samperiz, Ruth Caballero, Francesco Dentali, Pierpaolo Di Micco, Paolo Prandoni, Cecilia Becattini, Fernando Uresandi, Peter Verhamme, Manuel Monreal, the RIETE investigators the RIETE investigators,